Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Journal of Biomedical Materials Research. Part A
|
July 4, 2007
Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials
Jacqueline A Jones, Amy K McNally, David T Chang, et al.
Immunobiology
|
September 21, 2010
Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis
Zhidan Tu, Qing Li, Hong-Shiue Chou, et al.
British Journal of Haematology
|
December 24, 2005
Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device
Willem J van Heeckeren, Jennifer Vollweiler, Pingfu Fu, et al.
Blood Advances
|
November 3, 2023
Loss of GSK3β in hematopoietic stem cells results in normal hematopoiesis in mice
Grace Lee, Jude Franklin, Kalpana Gupta, et al.
British Journal of Haematology
|
October 23, 2023
IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1-like B-acute lymphoblastic leukaemia
Catherine K Gestrich, Shanelle J De Lancy, Adam Kresak, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 12, 2018
Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia
Fahrettin Covut, Divya Gupta, Raisa Pinto, et al.
Nature Communications
|
October 16, 2022
HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia
Qianze Dong, Yan Xiu, Yang Wang, et al.
Hematology (Amsterdam, Netherlands)
|
January 21, 2017
Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era
Adam G Starr, Paolo F Caimi, PingFu Fu, et al.
British Journal of Haematology
|
July 23, 2016
Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era
Adam G Starr, Paolo F Caimi, PingFu Fu, et al.
British Journal of Haematology
|
March 9, 2016
Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes
Adam G Starr, Paolo F Caimi, PingFu Fu, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Journal of Biomedical Materials Research. Part A
|
July 4, 2007
Matrix metalloproteinases and their inhibitors in the foreign body reaction on biomaterials
Jacqueline A Jones, Amy K McNally, David T Chang, et al.
Immunobiology
|
September 21, 2010
Complement mediated hepatocytes injury in a model of autoantibody induced hepatitis
Zhidan Tu, Qing Li, Hong-Shiue Chou, et al.
British Journal of Haematology
|
December 24, 2005
Randomised comparison of two B-cell purging protocols for patients with B-cell non-Hodgkin lymphoma: in vivo purging with rituximab versus ex vivo purging with CliniMACS CD34 cell enrichment device
Willem J van Heeckeren, Jennifer Vollweiler, Pingfu Fu, et al.
Blood Advances
|
November 3, 2023
Loss of GSK3β in hematopoietic stem cells results in normal hematopoiesis in mice
Grace Lee, Jude Franklin, Kalpana Gupta, et al.
British Journal of Haematology
|
October 23, 2023
IGJ and SPATS2L immunohistochemistry sensitively and specifically identify BCR::ABL1+ and BCR::ABL1-like B-acute lymphoblastic leukaemia
Catherine K Gestrich, Shanelle J De Lancy, Adam Kresak, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
December 12, 2018
Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia
Fahrettin Covut, Divya Gupta, Raisa Pinto, et al.
Nature Communications
|
October 16, 2022
HSF1 is a driver of leukemia stem cell self-renewal in acute myeloid leukemia
Qianze Dong, Yan Xiu, Yang Wang, et al.
Hematology (Amsterdam, Netherlands)
|
January 21, 2017
Splenic marginal zone lymphoma: excellent outcomes in 64 patients treated in the rituximab era
Adam G Starr, Paolo F Caimi, PingFu Fu, et al.
British Journal of Haematology
|
July 23, 2016
Dual institution experience of nodal marginal zone lymphoma reveals excellent long-term outcomes in the rituximab era
Adam G Starr, Paolo F Caimi, PingFu Fu, et al.
British Journal of Haematology
|
March 9, 2016
Dual institution experience of extranodal marginal zone lymphoma reveals excellent long-term outcomes
Adam G Starr, Paolo F Caimi, PingFu Fu, et al.
Page
of 6